248 related articles for article (PubMed ID: 35053384)
21. CRISPR/Cas9-edited Pax6-GFP reporter system facilitates the generation of mouse neural progenitor cells during differentiation.
Li Y; Li X; Wang H; Gao Q; Zhang J; Zhang W; Zhang Z; Li L; Yu Y; Shuai L
J Genet Genomics; 2018 May; 45(5):277-280. PubMed ID: 29803732
[No Abstract] [Full Text] [Related]
22. Generation of a PXR reporter human induced pluripotent stem cell line (PXR-mCherry hiPSC) using the CRISPR/Cas9 system.
Kim H; Kim JW; Kim SJ; Choi YJ; Kim DS; Park HJ
Stem Cell Res; 2018 Jan; 26():72-75. PubMed ID: 29247817
[TBL] [Abstract][Full Text] [Related]
23. Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the
Bhagwan JR; Collins E; Mosqueira D; Bakar M; Johnson BB; Thompson A; Smith JGW; Denning C
F1000Res; 2019; 8():1911. PubMed ID: 32789000
[No Abstract] [Full Text] [Related]
24. CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes.
Chirikian O; Goodyer WR; Dzilic E; Serpooshan V; Buikema JW; McKeithan W; Wu H; Li G; Lee S; Merk M; Galdos F; Beck A; Ribeiro AJS; Paige S; Mercola M; Wu JC; Pruitt BL; Wu SM
Sci Rep; 2021 Feb; 11(1):3026. PubMed ID: 33542270
[TBL] [Abstract][Full Text] [Related]
25. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
Ben Jehuda R; Shemer Y; Binah O
Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
[TBL] [Abstract][Full Text] [Related]
26. Evidence of functional duplicity of Nestin expression in the adult mouse midbrain.
Farzanehfar P; Lu SS; Dey A; Musiienko D; Baagil H; Horne MK; Aumann TD
Stem Cell Res; 2017 Mar; 19():82-93. PubMed ID: 28088038
[TBL] [Abstract][Full Text] [Related]
27. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
28. CRISPR/Cas9-Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells.
Sharma A; Toepfer CN; Ward T; Wasson L; Agarwal R; Conner DA; Hu JH; Seidman CE
Curr Protoc Hum Genet; 2018 Jan; 96():21.11.1-21.11.20. PubMed ID: 29364519
[TBL] [Abstract][Full Text] [Related]
29. Generation of Monoclonal iPSC Lines with Stable Cas9 Expression and High Cas9 Activity.
Liao JQ; Zhou G; Zhou Y
Methods Mol Biol; 2022; 2454():575-588. PubMed ID: 32567018
[TBL] [Abstract][Full Text] [Related]
30. Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing.
Gulimiheranmu M; Li S; Zhou J
Stem Cell Res; 2022 Jul; 62():102805. PubMed ID: 35576811
[TBL] [Abstract][Full Text] [Related]
31. Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking.
Anderson RH; Kerkvliet JG; Otta JJ; Ross AD; Leiferman PC; Hoppe AD; Francis KR
Stem Cell Res; 2018 Dec; 33():95-99. PubMed ID: 30340091
[TBL] [Abstract][Full Text] [Related]
32. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
[TBL] [Abstract][Full Text] [Related]
33. Generation of a human iPSC line CIBi010-A with a reporter for ASGR1 using CRISPR/Cas9.
Fu J; Jiang L; Yu B; Liu Y; Wei R; Hu Y; Ho WI; Yang B; Chu M; Tse HF; Yang J
Stem Cell Res; 2022 Jul; 62():102800. PubMed ID: 35561459
[TBL] [Abstract][Full Text] [Related]
34. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
35. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
[TBL] [Abstract][Full Text] [Related]
36. Generation of eight hiPSCs lines from two pathogenic variants in CACNA1A using the CRISPR-Cas9 gene editing technology.
Rivera-Sánchez P; Søndergaard L; Wathikthinnakon M; B D Magnusson H; Frederiksen HR; Aabæk Hammer F; Taleb R; Christian Cassidy C; Tranholm Bruun M; Tümer Z; Holst B; Brasch-Andersen C; Møller RS; Freude K; Chandrasekaran A
Stem Cell Res; 2023 Sep; 71():103193. PubMed ID: 37651830
[TBL] [Abstract][Full Text] [Related]
37. Targeting the AAVS1 Site by CRISPR/Cas9 with an Inducible Transgene Cassette for the Neuronal Differentiation of Human Pluripotent Stem Cells.
Gu J; Rollo B; Sumer H; Cromer B
Methods Mol Biol; 2022; 2495():99-114. PubMed ID: 35696030
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells.
Chandrasekaran A; Avci HX; Ochalek A; Rösingh LN; Molnár K; László L; Bellák T; Téglási A; Pesti K; Mike A; Phanthong P; Bíró O; Hall V; Kitiyanant N; Krause KH; Kobolák J; Dinnyés A
Stem Cell Res; 2017 Dec; 25():139-151. PubMed ID: 29128818
[TBL] [Abstract][Full Text] [Related]
39. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
[TBL] [Abstract][Full Text] [Related]
40. Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery.
De Masi C; Spitalieri P; Murdocca M; Novelli G; Sangiuolo F
Hum Genomics; 2020 Jun; 14(1):25. PubMed ID: 32591003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
